Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings

Jemal, 2008, Cancer statistics, 2008, CA Cancer J Clin, 58, 71, 10.3322/CA.2007.0010

Ozols, 2005, Epithelial ovarian cancer, 919

Bristow, 2002, Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis, J Clin Oncol, 20, 1248, 10.1200/JCO.20.5.1248

Hoskins, 1994, The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma, Am J Obstet Gynecol, 170, 974, 10.1016/S0002-9378(94)70090-7

Vergote, 2010, Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer, N Engl J Med, 363, 943, 10.1056/NEJMoa0908806

Axtell, 2007, Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer, J Clin Oncol, 25, 384, 10.1200/JCO.2006.07.7800

Brockbank, 2004, Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer, Int J Gynecol Cancer, 14, 42, 10.1111/j.1048-891x.2004.14065.x

Chi, 2000, The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma, Gynecol Oncol, 77, 227, 10.1006/gyno.2000.5749

Cooper, 2002, Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer, Obstet Gynecol, 100, 59

Dowdy, 2004, The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma, Cancer, 101, 346, 10.1002/cncr.20376

Gemer, 2001, Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer, Acta Obstet Gynecol Scand, 80, 583, 10.1080/j.1600-0412.2001.080006583.x

Memarzadeh, 2003, CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer, Int J Gynecol Cancer, 13, 120, 10.1046/j.1525-1438.2003.13019.x

Saygili, 2002, Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?, Gynecol Oncol, 86, 57, 10.1006/gyno.2002.6719

Gemer, 2005, A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer, Eur J Surg Oncol, 31, 1006, 10.1016/j.ejso.2005.05.009

Nelson, 1993, Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma, J Clin Oncol, 11, 166, 10.1200/JCO.1993.11.1.166

Bristow, 2000, A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography, Cancer, 89, 1532, 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A

Meyer, 1995, Ovarian carcinoma: value of CT in predicting success of debulking surgery, AJR Am J Roentgenol, 165, 875, 10.2214/ajr.165.4.7676985

Qayyum, 2005, Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer, Gynecol Oncol, 96, 301, 10.1016/j.ygyno.2004.06.054

Fader, 2007, Role of surgery in ovarian carcinoma, J Clin Oncol, 25, 2873, 10.1200/JCO.2007.11.0932

Byrom, 2002, Can pre-operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy?, BJOG, 109, 369, 10.1111/j.1471-0528.2002.01216.x

Forstner, 1995, Ovarian cancer: staging with CT and MR imaging, Radiology, 197, 619, 10.1148/radiology.197.3.7480729

Wakabayashi, 2008, The role of cytoreductive/debulking surgery in ovarian cancer, J Natl Compr Canc Netw, 6, 803, 10.6004/jnccn.2008.0060

Suh-Burgmann, 2007, Cytoreductive surgery for gynecologic malignancies—new standards of care, Surg Oncol Clin N Am, 16, 667, 10.1016/j.soc.2007.04.017